The calculation shows absolute and relative frequencies of subjects using resources plus their mean frequencies of utilization (visits or days of stay) over the past 12 months.
These included demographic factors (age and sex), health care utilization (visits to providers for gout both prior to and after ULD initiation, all provider visits prior to ULD initiation, and number of hospitalizations prior to ULD initiation), specific comorbidities, other medications used to treat symptomatic gout, and medications that can trigger gout.
The aim of the current study was to determine the extent to which health care utilization (physician visits, ED visits, hospitalizations) as measured by administrative data claims was reduced following the tele-CDSMP.
Outcomes included HRQoL (Short Form [SF]-36v2), health utilities (SF-six dimension [6D]), productivity loss (Work Productivity and Activity Impairment questionnaire), and resource utilization (provider visits, emergency room visits, and hospitalizations) in the past 6 months.
Housing status, utilization (ambulatory visits, emergency department (ED) visits, and hospitalizations) and other features were assessed with standardized research interviews at 6-month intervals.
Economic measures included the number of emergency department (ED) visits, hospitalizations, and outpatient care utilization (clinic visits).
Type 2 diabetes-related health care resource utilization (physician visits, hospitalizations, and auxiliary provider visits: diabetes educators, ophthalmologists, podiatrists, cardiologists, dietitians, and nephrologists), most recent recorded laboratory, biometric, and vital sign values, and other comorbidities were also assessed, but limited to the period 6 months prior to the baseline visit.
These summary data include marked changes in MLP utilization: PA visits rose from 2.9%to9.9%9%, while NP visits rose from 1.1%to4.7%7% (both Ptrend < 0.001).
We expect the interventions may affect two types of healthcare utilization: outpatient visits (including both primary care and specialist visits for OA-related care) and pain medication use.
Processes of care indicators (percent receiving A1c measurements, lipid profiles, serum creatinine, annual eye examination), health care utilization (mean visits to primary care physician) and outcomes (emergency room visits and hospital admissions) were collected.
